By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MicroRNA-based technology startup Firefly BioWorks has raised about $2 million in a private financing, which it plans to use to test its platform directed at cancer-related research.

Firefly co-founder and CEO Davide Marini, told GenomeWeb Daily News that the company plans to test the product with a select group of researchers to assess its utility but declined to provide further details. He also declined to identify investors in the round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.